Nuvectis Pharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $26,796 | $0 |
Gross Profit | 13,398 | -4,359 | ||
EBITDA | -6,334 | -5,568 | -6,449 | -4,359 |
EBIT | -6,595 | -5,568 | -6,449 | -4,359 |
Net Income | -6,334 | -5,332 | -6,248 | -4,153 |
Net Change In Cash | 0 | 0 | 26,796 | 0 |
Free Cash Flow | -3,367 | -4,174 | -2,465 | -2,404 |
Cash | 26,793 | 29,864 | 18,533 | 17,169 |
Basic Shares | 21,366 | 19,937 | 17,113 | 17,230 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $149 | $0 |
Gross Profit | -22,897 | -19,085 | -12,894 | |
EBITDA | -19,000 | -22,897 | -18,936 | -12,890 |
EBIT | -19,847 | -21,897 | -19,234 | -12,894 |
Net Income | -19,000 | -22,260 | -18,787 | -12,886 |
Net Change In Cash | 0 | 0 | 149 | 0 |
Cost of Revenue | 14,251 | |||
Free Cash Flow | -12,247 | -15,954 | -13,559 | -9,504 |
Cash | 18,533 | 19,126 | 19,993 | 5,742 |
Basic Shares | 17,113 | 15,556 | 12,657 | 12,717 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.30 |
2025-03-31 | -$0.27 |
2024-12-31 | -$0.35 |
